压力诱导的矩阵金属蛋白酶-9有助于早期高血压重塑
Stéphanie Lehoux1, Catherine A Lemarié, Bruno Esposito
1INSERM U541, Hôpital Lariboisière, 41 boulevard de la Chapelle, 75010 Paris, France. lehoux@larib.inserm.fr
Circulation
|February 18, 2004
概括
高血压通过激活矩阵金属蛋白酶 (MMPs) 来改变血管结构. MMP-9对于早期高血压血管改造和血管延展性至关重要.
科学领域:
- 心血管生物学 心血管生物学
- 血管改造是指进行血管改造.
- 细胞外矩阵动力学
背景情况:
- 高血压导致血管壁的结构变化,包括细胞外基质组成的改变.
- 这些高血压血管变化背后的精确机制仍然不完全理解.
研究的目的:
- 为了研究矩阵金属蛋白酶 (MMPs) 在血管壁对升高的内压力的反应中的作用.
- 阐明MMP-2和MMP-9对压力诱导的血管改造的具体贡献.
主要方法:
- 在不同内压力下 (10,80和150毫米平) 的小鼠动脉器官培养.
- 凝囊图和免疫组织化学评估MMP-2和MMP-9的活性和局部化.
- 测量压力-直径关系以评估血管延伸能力.
- 药理上抑制MMP和使用MMP-9缺乏小鼠的研究.
主要成果:
- 升高的压力 (150 mm Hg) 显著增加了MMP-2和MMP-9在心脏动脉中的活性.
- 高压诱导了较大的血管张张,这与MMP激活有关,并通过MMP抑制来预防.
- 缺乏MMP-9的小鼠表现出消除了压力诱导的延展性,尽管保持了MMP-2活性.
结论:
- 矩阵金属蛋白酶-9 (MMP-9) 在高血压血管重塑的早期阶段起着至关重要的作用.
- 对于高血压反应中观察到的血管张张能力的压力依赖增加,MMP-9是必不可少的.
更多相关视频
相关概念视频
Hormonal Regulation
30.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.4K
Role of Matrix Metalloproteases in Degradation of ECM
2.9K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K


